Evaluating Cellular Impedance Assays for Detection of GPCR Pleiotropic Signaling and Functional Selectivity

Abstract

G-protein—coupled receptors can couple to different signal transduction pathways in different cell types (termed cell-specific signaling) and can activate different signaling pathways depending on the receptor conformation(s) stabilized by the activating ligand (functional selectivity). These concepts offer potential for developing pathway-specific drugs that increase efficacy and reduce side effects. Despite significant interest, functional selectivity has been difficult to exploit in drug discovery, in part due to the burden of multiple assays. Cellular impedance assays use an emerging technology that can qualitatively distinguish Gs, Gi/o, and Gq signaling in a single assay and is thereby suited for studying these pharmacological concepts. Cellular impedance confirmed cell-specific Gs and Gq coupling for the melanocortin-4 receptor and dual Gi and Gs signaling with the cannabinoid-1 (CB1) receptor. The balance of Gi versus Gs signaling depended on the cell line. In CB1-HEKs, Giand Gs-like responses combined to yield a novel impedance profile demonstrating the dynamic nature of these traces. Cellspecific signaling was observed with endogenous D1 receptor in U-2 cells and SK-N-MC cells, yet the pharmacological profile of partial and full agonists was similar in both cell lines. We conclude that the dynamic impedance profile encodes valuable relative signaling information and is sufficiently robust to help evaluate cell-specific signaling and functional selectivity. (Journal of Biomolecular Screening 2009:246-255)

Keywords

GPCR cellular impedance assays functional selectivity biased-agonism

References

Urban JD , Clarke WP , von Zastrow M. , Nichols DE , Kobilka B. , Weinstein H. , et al: Functional selectivity and classical concepts of quantitative pharmacology. J Pharmacol Exp Ther 2007;320:1-13.

Galandrin S. , Oligny-Longpré G. , Bouvier M. : The evasive nature of drug efficacy: implications for drug discovery. Trends Pharmacol Sci 2007 ; 28:423-430.

Kenakin T. : Functional selectivity through protean and biased agonism: who steers the ship? Mol Pharmacol 2007;72:1393-1401.

Giaever I and Keese CR : A morphological biosensor for mammalian cells . Nature 1993;366:591-592.

Verdonk E. , Johnson K. , McGuinness R. , Leung G. , Chen YW , Tang HR , et al: Cellular dielectric spectroscopy: a label-free comprehensive platform for functional evaluation of endogenous receptors. Assay Drug Dev Technol 2006;4:609-619.

Yu N. , Atienza JM , Bernard J. , Blanc S. , Zhu J. , Wang X. , et al: Real-time monitoring of morphological changes in living cells by electronic cell sensor arrays: an approach to study G protein-coupled receptors . Anal Chem 2006;78:35-43.

Lee PH , Gao A. , van Staden C. , Ly J. , Salon J. , Xu A. , et al: Evaluation of dynamic mass redistribution technology for pharmacological studies of recombinant and endogenously expressed G protein-coupled receptors . Assay Drug Dev Technol 2008;6:83-94.

Peters MF , Knappenberger KS , Wilkins D. , Sygowski LA , Lazor LA , Liu J. , et al: Evaluation of cellular dielectric spectroscopy, a whole-cell, label-free technology for drug discovery on Gi-coupled GPCRs. J Biomol Screen 2007;12:312-319.

Giaever I. , Keese CR : Micromotion of mammalian cells measured electrically. Proc Natl Acad Sci U S A 1991;88:7896-7900.

10.

Dutt P. , Kjoller L. , Giel M. , Hall A. , Toksoz D. : Activated Galphaq family members induce Rho GTPase activation and Rho-dependent actin filament assembly. FEBS Lett 2002;531:565-569.

11.

Cant SH , Pitcher JA : G protein-coupled receptor kinase 2-mediated phosphorylation of ezrin is required for G protein-coupled receptor-dependent reorganization of the actin cytoskeleton . Mol Biol Cell 2005;16:3088-3099.

12.

Singh I. , Knezevic N. , Ahmmed GU , Kini V. , Malik AB , Mehta D. : Galphaq-TRPC6-mediated Ca2+ entry induces RhoA activation and resultant endothelial cell shape change in response to thrombin. J Biol Chem 2007;282:7833-7843.

13.

Street M. , Marsh SJ , Stabach PR , Morrow JS , Brown DA , Buckley NJ : Stimulation of Galphaq-coupled M1 muscarinic receptor causes reversible spectrin redistribution mediated by PLC, PKC and ROCK. J Cell Sci 2006;119:1528-1536.

14.

Pritchard LE , Armstrong D. , Davies N. , Oliver RL , Schmitz CA , Brennand JC , et al: Agouti-related protein (83-132) is a competitive antagonist at the human melanocortin-4 receptor: no evidence for differential interactions with pro-opiomelanocortin-derived ligands. J Endocrinol 2004;180:183-191.

15.

Newman EA , Chai BX , Zhang W. , Li JY , Ammori JB , Mulholland MW : Activation of the melanocortin-4 receptor mobilizes intracellular free calcium in immortalized hypothalamic neurons. J Surg Res 2006;132: 201-207.

16.

Bonhaus DW , Chang LK , Kwan J. , Martin GR : Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular responses . J Pharmacol Exp Ther 1998;287:884-888.

17.

Glass M. , Felder CC : Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J Neurosci 1997;17:5327-5333.

18.

Hampson RE , Mu J. , Deadwyler SA : Cannabinoid and kappa opioid receptors reduce potassium K current via activation of G(s) proteins in cultured hippocampal neurons. J Neurophysiol 2000;84:2356-2364.

19.

Kenakin T. : Differences between natural and recombinant G protein-coupled receptor systems with varying receptor/G protein stoichiometry. Trends Pharmacol Sci 1997;18:456-464.

20.

Hermans E. : Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors. Pharmacol Ther 2003;99:25-44.

21.

Sidhu A. : Regulation and expression of D-1, but not D-5, dopamine receptors in human SK-N-MC neuroblastoma cells. J Recept Signal Transduct Res 1997;17:777-784.

22.

Ryman-Rasmussen JP , Nichols DE , Mailman RB : Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists. Mol Pharmacol 2005;68:1039-1048.

23.

Ryman-Rasmussen JP , Griffith A. , Oloff S. , Vaidehi N. , Brown JT , Goddard WA 3rd , et al: Functional selectivity of dopamine D1 receptor agonists in regulating the fate of internalized receptors. Neuropharmacology 2007;52:562-575.

24.

Selkirk JV , Nottebaum LM , Lee J. , Yang W. , Foster AC , Lechner SM : Identification of differential melanocortin 4 receptor agonist profiles at natively expressed receptors in rat cortical astrocytes and recombinantly expressed receptors in human embryonic kidney cells. Neuropharmacology 2007;52:459-466.

25.

Shen CP , Xiao JC , Armstrong H. , Hagmann W. , Fong TM : F200A substitution in the third transmembrane helix of human cannabinoid CB1 receptor converts AM2233 from receptor agonist to inverse agonist. Eur J Pharmacol 2006;531:41-46.

26.

Beischlag TV , Marchese A. , Meador-Woodruff JH , Damask SP , O'Dowd BF , Tyndale RF , et al: The human dopamine D5 receptor gene: cloning and characterization of the 5'-flanking and promoter region. Biochemistry 1995;34:5960-5970.

27.

Kimura K. , Sela S. , Bouvier C. , Grandy DK , Sidhu A. : Differential coupling of D1 and D5 dopamine receptors to guanine nucleotide binding proteins in transfected GH4C1 rat somatomammotrophic cells. J Neurochem 1995;64:2118-2124.

28.

Kimura K. , White BH , Sidhu A. : Coupling of human D-1 dopamine receptors to different guanine nucleotide binding proteins. Evidence that D-1 dopamine receptors can couple to both Gs and G(o) . J Biol Chem 1995;270:14672-14678.

29.

Yao WD , Spealman RD , Zhang J. : Dopaminergic signaling in dendritic spines. Biochem Pharmacol 2008;75:2055-2069.

30.

Giaever I. , Keese CR : Monitoring fibroblast behavior in tissue culture with an applied electric field. Proc Natl Acad Sci U S A 1984;81:3761-3764.

31.

He JC , Neves SR , Jordan JD , Iyengar R. : Role of the Go/i signaling network in the regulation of neurite outgrowth . Can J Physiol Pharmacol 2006;84:687-694.

32.

Ueda H. , Morishita R. , Yamauchi J. , Itoh H. , Kato K. , Asano T. : Regulation of Rac and Cdc42 pathways by G(i) during lysophosphatidic acid-induced cell spreading. J Biol Chem 2001 ;276:6846-6852.

33.

Pelletier S. , Julien C. , Popoff MR , Lamarche-Vane N. , Meloche S. : Cyclic AMP induces morphological changes of vascular smooth muscle cells by inhibiting a Rac-dependent signaling pathway . J Cell Physiol 2005;204:412-422.

34.

Reddy L. , Wang HS , Keese CR , Giaever I. , Smith TJ : Assessment of rapid morphological changes associated with elevated cAMP levels in human orbital fibroblasts. Exp Cell Res 1998;245:360-367.

35.

Chaldakov GN , Nabika T. , Nara Y. , Yamori Y. : Cyclic AMP- and cytochalasin B-induced arborization in cultured aortic smooth muscle cells: its cytopharmacological characterization . Cell Tissue Res 1989;255:435-442.

36.

Laroche G. , Rochdi MD , Laporte SA , Parent JL : Involvement of actin in agonist-induced endocytosis of the G protein-coupled receptor for thromboxane A2: overcoming of actin disruption by arrestin-3 but not arrestin-2. J Biol Chem 2005;280:23215-23224.

37.

Volovyk ZM , Wolf MJ , Prasad SV , Rockman HA : Agonist-stimulated beta-adrenergic receptor internalization requires dynamic cytoskeletal actin turnover. J Biol Chem 2006 ;281:9973-9780.